Chemoselectively addressable template: A valuable tool for the engineering of molecular conjugates

Journal of Organic Chemistry

Volumn 71, Issue 6, 2006, Pages 2402-2410

  Garanger, Elisabeth ^a   Boturyn, Didier ^a   Renaudet, Olivier ^a   Defrancq, Eric ^a   Dumy, Pascal ^a  

^a Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TARGETING FUNCTION; CHEMOSELECTIVELY ADDRESSABLE TEMPLATE; CHEMOSELECTIVELY ADDRESSABLE TEMPLATE (CAT); CYCLIC PEPTIDE TEMPLATE; CYTOTOXIC PEPTIDE; ITERATIVE OXIME BONDS; MODULAR DESIGN; MOLECULAR CONJUGATES; OLIGONUCLEOTIDE; POTENTIAL CYTOTOXIC MOLECULES;

ALDEHYDES; ASSEMBLY; CELLS; CHEMICAL BONDS; ITERATIVE METHODS; MOLECULAR WEIGHT DISTRIBUTION; OLIGOMERS; SYNTHESIS (CHEMICAL);

MOLECULES;

ALDEHYDE; CYCLOPEPTIDE; CYTOTOXIC AGENT; OLIGONUCLEOTIDE; OXIME; SERINE; VITRONECTIN RECEPTOR;

ARTICLE; CHEMICAL BOND; CHEMICAL ENGINEERING; MOLECULAR WEIGHT; REACTION ANALYSIS; STEREOCHEMISTRY; SYNTHESIS;

ALDEHYDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INTEGRIN ALPHAVBETA3; LIGANDS; MOLECULAR CONFORMATION; OXIMES; PEPTIDES, CYCLIC; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SURFACE PROPERTIES;

EID: 33645022683     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0525480     Document Type: Article

References (48)

1. Magrath, I. T. Int. J. Cancer 1994, 56, 163-166.
2. Boturyn, D.; Coll, J.-L.; Garanger, E.; Favrot, M.-C.; Dumy, P. J. Am. Chem. Soc. 2004, 126, 5730-5739.
3. (a) Dumy, P.; Eggleston, I. M.; Cervigni, S.; Sila, U.; Sun, X.; Mutter, M. Tetrahedron Lett. 1995, 38, 1255-1258.
4. (b) Peluso, S.; Ruckle, T.; Lehmann, C.; Mutter, M.; Peggion, C.; Crisma, M. ChemBioChem 2001, 2, 432-437
5. (c) Dumy, P.; Eggleston, I. M.; Esposito, G.; Nicula, S.; Mutter, M. Biopolymers 1996, 39, 297-308.
6. (a) Haubner, R.; Gratias, R.; Diefenbach, B.; Goodman, S. L.; Jonczyk, A.; Kessler, H. J. Am. Chem. Soc. 1996, 118, 7461-7472.
7. (b) Haubner, R.; Finsinger, D.; Kessler, H. Angew. Chem., Int. Ed. Engl. 1997, 36, 1374-1389.
8. Garanger, E.; Boturyn, D.; Jin, Z.; Dumy, P.; Favrot, M.-C.; Coll, J.-L. Mol. Therapy 2005, 12, 1168-1175.
9. For reviews on chemoselective ligations, see: (a) Dawson, P. E.; Kent, S. B. H. Annu. Rev. Biochem. 2000, 69, 923-960.
10. (b) Lemieux, G. A.; Bertozzi, C. R. Trends Biotechnol. 1998, 16, 506-513.
11. (a) Verez-Bencomo, V.; Fernandez-Santana, V.; Hardy, E.; Toledo, M. E.; Rodríguez, M. C.; Heynngnezz, L.; Rodriguez, A.; Baly, A.; Herrera, L.; Izquierdo, M.; Villar, A.; Valdés, Y.; Cosme, K.; Deler, M. L.; Montane, M.; Garcia, E.; Ramos, A.; Aguilar, A.; Medina, E.; Toraño, G.; Sosa, I.; Hernandez, I.; Martinez, R.; Muzachio, A.; Carmenates, A.; Costa, L.; Cardoso, F.; Campa, C.; Diaz, M.; Roy, R. Science 2004, 305, 522-525.
12. (b) Zeng, W.; Jackson, D. C.; Murray, J.; Rose, K.; Brown, L. E. Vaccine 2000, 18, 1031-1039.
13. (c) Rose, K.; Zeng, W.; Brown, L. E.; Jackson, D. C. Mol. Immunol. 1995, 32, 1031-1037.
14. (d) Zeng, W.; Ghosh, S.; Macris, M.; Pagnon, J.; Jackson, D. C. Vaccine 2001, 19, 3843-3852.
15. (a) Rose, K. J. Am. Chem. Soc. 1994, 116, 30-33.
16. (b) Canne, L. E.; Ferré-D' Amaré, A. R.; Burley, S. K.; Kent S. B. H. J. Am. Chem. Soc. 1995, 117, 2998-3007.
17. (c) Hartley, O.; Gaertner, H.; Wilken, J.; Thompson, D.; Fish, R.; Ramos, A.; Pastore, C.; Dufour, B.; Cerini, F.; Melotti, A.; Heveker, N.; Picard, L.; Alizon, M.; Mosier, D.; Kent, S. B.; Offord, R. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 16460-16465.
18. Naicker, K. P.; Li, H.; Heredia, A.; Song H.; Wang, L.-X. Org. Biomol. Chem. 2004, 2, 660-664.
19. Henry, M. D.; Wen, S.; Silva, M. D.; Chandra, S.; Milton, M.; Worland, P. J. Cancer Res. 2004, 64, 7995-8001.
20. (a) Forget, D.; Boturyn, D.; Defrancq, E.; Lhomme, J.; Dumy, P. Chem. Eur. J. 2001, 7, 3976-3984.
21. (b) Zatsepin, T. S.; Stetsenko, D. A.; Arzumanov, A. A.; Romanova, E. A.; Gait, M. J.; Oretskaya, T. S. Bioconjugate Chem. 2002, 13, 822-830.
22. (c) Renaudet, O.; Dumy, P. Org. Lett. 2003, 5, 243-246.
23. (d) Grigalevicius, S.; Chierici, S.; Renaudet, O.; Lo-Man, R.; Deriaud, E.; Leclerc, C.; Dumy, P. Bioconjugate Chem. 2005, 16, 1149-1159.
24. (e) Singh, Y.; Renaudet, O.; Defrancq, E.; Dumy, P. Org. Lett. 2005, 7, 1359-1362.
25. Jenks, W. P. J. Am. Chem. Soc. 1959, 81, 475-481.
26. (a) Nardin, E. H.; Calvo-Calle, J. M.; Oliveira, G. A.; Clavijo, P.; Nussenzweig, R.; Simon, R.; Zeng, W.; Rose, K. Vaccine 1998, 16, 590-600.
27. (b) Nardin, E. H.; Calvo-Calle, J. M.; Oliveira, G. A.; Nussenzweig, R. S.; Schneider, M.; Tiercy, J.-M.; Loutan, L.; Hochstrasser, D.; Rose, K. J. Immunol. 2001, 166, 481-489.
28. Chen, X.; Soo Lee, G.; Zettl, A.; Bertozzi, C. R. Angew. Chem., Int. Ed. 2004, 43, 6112-6116.
29. Zhao, Y.; Kent S. B. H.; Chait, B. T. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 1629-1633.
30. Cervigni, S. E.; Dumy, P.; Mutter, M. Angew. Chem., Int. Ed. Engl. 1996, 35, 1230-1232.
31. (a) Cremer, G.-A.; Bureaud, N.; Lelièvre, D.; Piller, V.; Piller, F.; Delmas, A. Chem. Eur. J. 2004, 10, 6353-6360.
32. (b) Lelievre, D.; Buré, C.; Laot, F.; Delmas, A. Tetrahedron Lett. 2001, 42, 235-238.
33. Edupuganti, O. P.; Singh, Y.; Defrancq, E.; Dumy, P. Chem. Eur. J. 2004, 10, 5988-5995.
34. Renaudet, O.; Reymond, J.-L. Org. Lett. 2003, 5, 4693-4696.
35. Chen, J.; Zeng, W.; Offord, R.; Rose, K. Bioconjugate Chem. 2003, 14, 614-618.
36. Geoghegan, K. F.; Stroh, J. G. Bioconjugate Chem. 1992, 3, 138-146.
37. (a) Polyakov, V. A.; Nelen, M. I.; Nazarpack-Kandlousy, N.; Ryabov, A. D.; Eliseev A. V. J. Phys. Org. Chem. 1999, 12, 357-363.
38. (b) Axelson, M. Anal. Biochem. 1978, 86, 133-141.
39. (c) Shao, H.; Crnogorac, M. M.; Kong, T.; Chen, S.-Y.; Williams, J. M.; Tack, J. M.; Gueriguian, V.; Cagle, E. N.; Carnevali, M.; Tumelty, D.; Paliard, X. Miranda, L. P.; Bradburne, J. A.; Kochendoerfer G. G. J. Am. Chem. Soc. 2005, 127, 1350-1351.
40. Thieret, N.; Alsina, J.; Giralt, E.; Guibé, F.; Albericio, F. Tetrahedron Lett. 1997, 38, 7275-7278.
41. Hocker, M. D.; Caldwell, C. G.; Macsata, R. W.; Lyttle, M. H. Peptide Res. 1995, 8, 310-315.
42. Boturyn, D.; Dumy, P. Tetrahedron Lett. 2001, 42, 2787-2790.
43. Mai, J. C.; Mi, Z.; Kim, S.-H.; Ng, B.; Robbins, P. D. Cancer Res. 2001, 61, 7709-7712.
44. (b) Javadpour, M. M.; Juban, M. M.; Lo, W. C.; Bishop, S. M.; Alberty, J. B.; Cowell, S. M.; Becker, C. L.; McLaughlin, M. L. J. Med. Chem. 1996, 39, 3107-3113.
45. After reaction, 2 equiv of benzyloxyamine was added to trap the slight excess of remaining aldehyde 16 and to facilitate the HPLC separation.
46. Jin, Z.; Garanger, E.; Boturyn, D.; Favrot, M.-C.; Dumy, P.; Coll, J.-C. Unpublished results.
47. The sequence was known as an inhibitor of luciferase gene expression and was chosen as an example of antisense oligonucleotide. Antopolsky, M.; Azhayeva, E.; Tengvall, U.; Auroila, S.; Jääskeläinen, I.; Rönkkö, S.; Honkakoski, P.; Urtti, A.; Lönnberg, H.; Azhayev, A. Bioconjugate Chem. 1999, 10, 598-606.
48. Shao, J.; Tam, J.-P. J. Am. Chem. Soc. 1995, 117, 3893-3899.